SAN DIEGO --(BUSINESS WIRE)--Jul. 29, 2021-- DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter ended June 30, 2021 . Second Quarter 2021 Financial Highlights: Revenue grew 32% versus the same quarter of the prior year to $595.1 million U.S.

Clearance expands connectivity and interoperability of the Dexcom CGM digital ecosystem Allows invited third-party developers to connect applications and devices to real-time CGM data Gives Dexcom users more choice in where and how they interact with their glucose data SAN DIEGO --(BUSINESS

SAN DIEGO --(BUSINESS WIRE)--Jul. 7, 2021-- DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its second quarter 2021 financial results after market close on Thursday, July 29, 2021 . Management will hold a conference call to review the company's second quarter 2021 performance

Conference programming reaffirms Dexcom CGM as central to improved diabetes management Showcases benefits of Dexcom CGM for broader populations beyond those on mealtime insulin Demonstrates the impact of Dexcom real-time CGM for inpatient monitoring SAN DIEGO --(BUSINESS WIRE)--Jun.

Time in range is a powerful metric for modern diabetes management—but a new survey finds not enough people with diabetes know about it or are using it 1 The Global Movement for Time in Range is an educational effort to broaden awareness of time in range and its benefits for people with diabetes and

BURNABY, British Columbia --(BUSINESS WIRE)--Jun. 22, 2021-- Dexcom , Inc. and Tandem Diabetes Care , Inc. are thrilled to announce their support of Sébastien Sasseville , a Canadian endurance athlete and person living with type 1 diabetes, as he attempts to cycle across Canada in 14 days.

Dexcom CGM use is proven to improve glycemic control 1,2   and can reduce the risk of costly long-term diabetes-related complications compared to fingerstick monitoring. 3 BURNABY, British Columbia --(BUSINESS WIRE)--Jun. 11, 2021-- Dexcom, Inc. (NASDAQ: DXCM), a leader in real-time continuous

Results of two new studies illustrate continued momentum for Dexcom CGM, including JAMA-published data on additional populations who can benefit from the technology SAN DIEGO --(BUSINESS WIRE)--Jun. 3, 2021-- DexCom, Inc. (Nasdaq: DXCM), the global leader in real-time continuous glucose monitoring

Dexcom CGM use is proven to improve glycemic control 1,2  and can reduce the risk of costly long-term diabetes-related complications compared to fingerstick monitoring. 3 BURNABY, BC , June 1, 2021 /CNW Telbec/ - Dexcom, Inc. (NASDAQ: DXCM), a leader in real-time continuous glucose monitoring

SAN DIEGO --(BUSINESS WIRE)--May 27, 2021-- DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on Dexcom at the following upcoming investor conference: Jereme Sylvain , Executive Vice President and Chief Financial Officer, will present on behalf of the company at the